The effect of tiaprofenic acid and indomethacin on vascular prostacyclin and platelet thromboxane A2 production.
Jeremy Jy, Barradas Ma, Mikhailidis Dp, Paresh Dandona
Abstract
Jeremy Jy, Barradas Ma, Mikhailidis Dp, Paresh Dandona
Abstract
Two experimental models were used to compare tiaprofenic acid and indomethacin. The first model involved assessing their effect on in vitro prostacyclin synthesis by rat aortic rings and human umbilical endothelial cells. The results showed that the inhibitory effect of the two drugs was similar. The second model involved assessing the effect of these drugs on in vitro thromboxane A2 release by human platelets. Indomethacin was shown to be a more potent inhibitor of TXA2 release than tiaprofenic acid, but this difference was only significant at low concentrations of the drugs; at concentrations equivalent to those achieved during routine treatment, both produced near maximal inhibition of TXA2 release by platelets. It is concluded that the findings do not support the claim that tiaprofenic acid is more 'selective' in its actions on these aspects of prostaglandin synthesis than another non-steroidal anti-inflammatory drug, indomethacin.
OpenAlex reports 14 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Two experimental models were used to compare tiaprofenic acid and indomethacin. The first model involved assessing their effect on in vitro prostacyclin synthesis by rat aortic rings and human umbilical endothelial cells. The results showed that the inhibitory effect of the two drugs was similar. The second model involved assessing the effect of these drugs on in vitro thromboxane A2 release by human platelets. Indomethacin was shown to be a more potent inhibitor of TXA2 release than tiaprofenic acid, but this difference was only significant at low concentrations of the drugs; at concentrations equivalent to those achieved during routine treatment, both produced near maximal inhibition of TXA2 release by platelets. It is concluded that the findings do not support the claim that tiaprofenic acid is more 'selective' in its actions on these aspects of prostaglandin synthesis than another non-steroidal anti-inflammatory drug, indomethacin.
Key concepts: Prostacyclin, Platelet, Thromboxane A2, Pharmacology, Thromboxane, Chemistry, Arachidonic acid, In vitro